Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients
INTRODUCTION: In the past, antiviral therapy has been given to 15% to 30% of patients infected with hepatitis C virus (HCV). The efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. The aim of the present study was to identify the clinical, socioeconomic...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2006/638272 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550485378203648 |
|---|---|
| author | Maciej Witkos Qi-Long Yi Jenny Heathcote Moira K Kapral Murray D Krahn |
| author_facet | Maciej Witkos Qi-Long Yi Jenny Heathcote Moira K Kapral Murray D Krahn |
| author_sort | Maciej Witkos |
| collection | DOAJ |
| description | INTRODUCTION: In the past, antiviral therapy has been given to 15% to 30% of patients infected with hepatitis C virus (HCV). The efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. The aim of the present study was to identify the clinical, socioeconomic and health-system predictors of antiviral treatment for HCV. |
| format | Article |
| id | doaj-art-51ff6fafd05f47d281f2f73c5b2017fe |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2006-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-51ff6fafd05f47d281f2f73c5b2017fe2025-02-03T06:06:35ZengWileyCanadian Journal of Gastroenterology0835-79002006-01-0120210711110.1155/2006/638272Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C PatientsMaciej Witkos0Qi-Long Yi1Jenny Heathcote2Moira K Kapral3Murray D Krahn4Department of Health Policy, Management and Evaluation, University of Toronto, Toronto General Hospital, CanadaDepartment of Public Health Sciences, Ontario Cancer Institute, Princess Margaret Hospital, CanadaToronto Western Hospital, University Health Network, Toronto, Ontario, CanadaDepartment of Health Policy, Management and Evaluation, University of Toronto, Toronto General Hospital, CanadaDepartment of Health Policy, Management and Evaluation, University of Toronto, Toronto General Hospital, CanadaINTRODUCTION: In the past, antiviral therapy has been given to 15% to 30% of patients infected with hepatitis C virus (HCV). The efficacy of therapy has recently improved with the addition of ribavirin and pegylated interferon. The aim of the present study was to identify the clinical, socioeconomic and health-system predictors of antiviral treatment for HCV.http://dx.doi.org/10.1155/2006/638272 |
| spellingShingle | Maciej Witkos Qi-Long Yi Jenny Heathcote Moira K Kapral Murray D Krahn Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients Canadian Journal of Gastroenterology |
| title | Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients |
| title_full | Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients |
| title_fullStr | Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients |
| title_full_unstemmed | Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients |
| title_short | Predictors of Antiviral Therapy in a Post-Transfusion Cohort of Hepatitis C Patients |
| title_sort | predictors of antiviral therapy in a post transfusion cohort of hepatitis c patients |
| url | http://dx.doi.org/10.1155/2006/638272 |
| work_keys_str_mv | AT maciejwitkos predictorsofantiviraltherapyinaposttransfusioncohortofhepatitiscpatients AT qilongyi predictorsofantiviraltherapyinaposttransfusioncohortofhepatitiscpatients AT jennyheathcote predictorsofantiviraltherapyinaposttransfusioncohortofhepatitiscpatients AT moirakkapral predictorsofantiviraltherapyinaposttransfusioncohortofhepatitiscpatients AT murraydkrahn predictorsofantiviraltherapyinaposttransfusioncohortofhepatitiscpatients |